
C&A Scientific
- Home
- Companies
- C&A Scientific
- Articles
- The Future of COVID-19 and Vaccinations
The Future of COVID-19 and Vaccinations
Feb. 1, 2021
Courtesy ofC&A Scientific
Coronavirus 2021
COVID-19 is nearing the one-year mark in the United States with over 26.2 million cases to date. While cases in the United States are still doubling their daily totals, many people worldwide are experiencing pandemic fatigue. Just before the end of 2020, companies like Moderna and Pfizer, with help from many C & A Scientific customers, were able to provide a solution by developing a series of vaccines to eligible patients, depending on which state you are in. As of February 1st, 31.8 million vaccines have been administered in the United States and 1.7% of people have received their second dose.
Most popular related searches
Stay in the loop!
Select your areas of interest to receive industry updates.